| 臺大學術典藏 |
2020-01-23T01:37:24Z |
The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: Results from a cross-sectional, population-based study
|
Liao L.; Wang J.-Y.; Liu M.; Sumarsono B.; Jong J.J.; Yoo T.K.; Lee K.-S.; Chuang Y.-C.; Liu S.-P.; PO-MING CHOW; Po-Ming Chow;Liu S.-P.;Chuang Y.-C.;Lee K.-S.;Yoo T.K.;Liao L.;Wang J.-Y.;Liu M.;Sumarsono B.;Jong J.J. |
| 臺大學術典藏 |
2020-01-23T01:37:24Z |
The prevalence and risk factors of nocturia in China, South Korea, and Taiwan: Results from a cross-sectional, population-based study
|
Liao L.; Wang J.-Y.; Liu M.; Sumarsono B.; Jong J.J.; Yoo T.K.; Lee K.-S.; Chuang Y.-C.; Liu S.-P.; PO-MING CHOW; Po-Ming Chow;Liu S.-P.;Chuang Y.-C.;Lee K.-S.;Yoo T.K.;Liao L.;Wang J.-Y.;Liu M.;Sumarsono B.;Jong J.J. |
| 臺大學術典藏 |
2020-01-23T01:37:24Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.;Liu K.-L.;Po-Ming Chow;Lin W.-C.;Tai H.-C.;Huang C.-Y.;Wang S.-M.;Huang K.-H.;Pu Y.-S.; Lien C.-C.; Liu K.-L.; PO-MING CHOW; Lin W.-C.; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2020-01-23T01:37:24Z |
Long-term outcomes of nephrectomy and inferior vena cava thrombectomy in patients with advanced renal cell carcinoma: A single-center experience
|
Lien C.-C.;Liu K.-L.;Po-Ming Chow;Lin W.-C.;Tai H.-C.;Huang C.-Y.;Wang S.-M.;Huang K.-H.;Pu Y.-S.; Lien C.-C.; Liu K.-L.; PO-MING CHOW; Lin W.-C.; Tai H.-C.; Huang C.-Y.; Wang S.-M.; Huang K.-H.; Pu Y.-S. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Huang K.-H.; Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Huang K.-H.; Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Po-Ming Chow;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW; Liao S.-M.; Yang S.-P.; Hong J.-Y. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Po-Ming Chow;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Huang K.-H.; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; PO-MING CHOW; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Po-Ming Chow;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Huang K.-H.; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; PO-MING CHOW; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.;Chiang C.-H.;Pu Y.-S.;Liu S.P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Huang K.-H.;Lee Y.-J.;Po-Ming Chow;Hung S.-C.;Huang C.-Y.; Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; PO-MING CHOW; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2020-01-23T01:37:23Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.;Chiang C.-H.;Pu Y.-S.;Liu S.P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Huang K.-H.;Lee Y.-J.;Po-Ming Chow;Hung S.-C.;Huang C.-Y.; Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; Huang K.-H.; Lee Y.-J.; PO-MING CHOW; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2020-01-23T01:37:22Z |
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center
|
Chen C.-H.; Chiang I.-N.; Lu Y.-C.; Hung S.-C.; Huang K.-H.; Huang C.-Y.; Chang H.-C.; Pu Y.-S.; PO-MING CHOW; Hong C.-H.; Tseng C.-S.; Tai T.-E.; Tseng C.-S.;Tai T.-E.;Hong C.-H.;Chen C.-H.;Chiang I.-N.;Lu Y.-C.;Hung S.-C.;Huang K.-H.;Huang C.-Y.;Chang H.-C.;Pu Y.-S.;Po-Ming Chow |
| 臺大學術典藏 |
2020-01-23T01:37:22Z |
Trifecta outcome of ureteral reconstruction in iatrogenic injury and non-iatrogenic ureteral lesions: a 10-year experience at a tertiary referral center
|
Chen C.-H.; Chiang I.-N.; Lu Y.-C.; Hung S.-C.; Huang K.-H.; Huang C.-Y.; Chang H.-C.; Pu Y.-S.; PO-MING CHOW; Hong C.-H.; Tseng C.-S.; Tai T.-E.; Tseng C.-S.;Tai T.-E.;Hong C.-H.;Chen C.-H.;Chiang I.-N.;Lu Y.-C.;Hung S.-C.;Huang K.-H.;Huang C.-Y.;Chang H.-C.;Pu Y.-S.;Po-Ming Chow |
| 臺大學術典藏 |
2020-01-23T01:37:21Z |
The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma
|
Po-Ming Chow;Liu S.-H.;Chang Y.-W.;Kuo K.-L.;Lin W.-C.;Huang K.-H.; PO-MING CHOW; Liu S.-H.; Chang Y.-W.; Kuo K.-L.; Lin W.-C.; Huang K.-H. |
| 臺大學術典藏 |
2020-01-23T01:37:21Z |
The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma
|
Po-Ming Chow;Liu S.-H.;Chang Y.-W.;Kuo K.-L.;Lin W.-C.;Huang K.-H.; PO-MING CHOW; Liu S.-H.; Chang Y.-W.; Kuo K.-L.; Lin W.-C.; Huang K.-H. |
| 臺大學術典藏 |
2019 |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Po-Ming Chow;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Huang K.-H.; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; PO-MING CHOW; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2019 |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Po-Ming Chow;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Huang K.-H.; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; PO-MING CHOW; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. |
